National and Kapodistrian University of Athens
Διερεύνηση δυσμενών προγνωστικών δεικτών προερχόμενων από το μικρό-περιβάλλον του όγκου στα επιθετικά B λεμφώματα
Abstract
dc:descriptionDiffuse large B-cell lymphoma (DLBCL) is the most common and aggressive form of non-Hodgkin ’s lymphoma, accounting for approximately 30-40% of cases. Despite advances in diagnostic and therapeutic approaches, it remains a heterogeneous entity, with significant variations in prognosis and therapeutic response. This heterogeneity arises from both molecular and genetic variations as well as the complexity of the tumor microenvironment (TME). The TME plays a critical role in therapeutic resistance and disease progression through immunosuppressive mechanisms and pro-inflammatory mediators. This study focused on unfavorable prognostic markers, including sCD163, IL-10, CCL2, CCL4, and MMP-9, which are associated with immune evasion, relapse, and therapy resistance. This study aimed to elucidate the mechanisms by which these markers affect tumor prognosis and progression. Identifying novel therapeutic targets within the TME could facilitate the development of personalized therapies and improve clinical outcomes in patients with DLBCL.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koudouna, Aspasia
- Κουδουνά, Ασπασία
Subjects
dc:subject × 16- Β-μη Hodgkin's λεμφώματα
- Μικροπεριβαλλον του όγκου (TME)
- Διαλυτός υποδοχέας CD163 (sCD163)
- Μεταλλοπρωτεϊνάση-9 (MMP-9)
- Μακροφάγα σχετιζόμενα με τον όγκο (TAMs)
- B non Hodgkin's lymphoma
- Tumor microenvironment (TME)
- Soluble receptor CD163 (sCD163)
- Metalloprotease - 9 ( MMP-9)
- Tumor associated Macrophages (TAMs)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Αιματολογία
- Clinical Medicine
- Medical and Health Sciences
- Hematology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59674